Effect of nitric oxide synthase on multiple drug resistance is related to Wnt signaling in non-small cell lung cancer

Li,Yang; Ma,Chengyuan; Shi,Xu; Wen,Zhongmei; Li,Dan; Sun,Munan; Ding,Hui

doi:10.3892/or.2014.3351

Effect of nitric oxide synthase on multiple drug resistance is related to Wnt signaling in non-small cell lung cancer

Authors:
- Yang Li
- Chengyuan Ma
- Xu Shi
- Zhongmei Wen
- Dan Li
- Munan Sun
- Hui Ding
View Affiliations

Affiliations: Department of Respiration, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China, Department of Neurosurgery, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China, Department of Central Laboratory of the First Affiliated Hospital, and College of Basic Medical Sciences, Jilin University, Changchun, Jilin 130021, P.R. China, Cancer Biotherapy Center, Jilin Province People's Hospital, Changchun, Jilin 130000, P.R. China
Published online on: July 23, 2014 https://doi.org/10.3892/or.2014.3351
Pages: 1703-1708

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Multiple drug resistance (MDR) is considered a major challenge in the clinical treatment of non-small cell lung cancer (NSCLC). Both nitric oxide synthase (iNOS) and Wnt signaling pathway participate in the regulation of drug resistance, but the interaction between them remains unclear. In the present study, we detected the activation of Wnt/β-catenin signaling in iNOS-induced drug-resistant lung cancer cells, and compared the effect of canonical and noncanonical Wnt pathway on the level of iNOS. Moreover, we investigated the expression of Wnt/β-catenin signaling downstream factors and its main inhibitors. The results indicated iNOS-induced drug resistance was possibly mediated by glutathione S-transferase-π (GST-π) and topoisomerase IIα (TOPO IIα), but not P-glycoprotein (P-gp), and this process was closely associated with the activation of canonical Wnt/β-catenin signaling, but less with noncanonical pathways. The mechanism of iNOS promoting Wnt/β-catenin pathway was mainly dependent on the inverse regulation of Dickkopf-1 (DKK-1) and secreted frizzled-related protein-1 (SFRP-1). Clarifying the relationship between iNOS and Wnt signaling may provide insight into a better understanding of the mechanism of drug resistance development in NSCLC.

View Figures

View References

1	Keith RL and Miller YE: Lung cancer chemoprevention: current status and future prospects. Nat Rev Clin Oncol. 10:334–343. 2013. View Article : Google Scholar : PubMed/NCBI
2	She J, Yang P, Hong Q and Bai C: Lung cancer in China: challenges and interventions. Chest. 143:1117–1126. 2013. View Article : Google Scholar : PubMed/NCBI
3	Yang Y, Li H, Hou S, Hu B, Liu J and Wang J: The noncoding RNA expression profile and the effect of lncRNA AK126698 on cisplatin resistance in non-small-cell lung cancer cell. PLoS One. 8:e653092013. View Article : Google Scholar : PubMed/NCBI
4	Grutters JPC, Kessels AGH, Pijls-Johannesma M, de Ruysscher D, Joore MA and Lambin P: Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: a meta-analysis. Radiother Oncol. 95:32–40. 2010. View Article : Google Scholar : PubMed/NCBI
5	Herbst R, Heymach J and Lippman S: Molecular origins of cancer. N Engl J Med. 359:1367–1380. 2008.
6	Schiller JH, Harrington D, Belani CP, et al: Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med. 346:92–98. 2002. View Article : Google Scholar
7	Scagliotti GV, Parikh P, von Pawel J, et al: Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol. 26:3543–3551. 2008. View Article : Google Scholar : PubMed/NCBI
8	Mackay HJ and Twelves CJ: Protein kinase C: a target for anticancer drugs? Endocr Relat Cancer. 10:389–396. 2003. View Article : Google Scholar : PubMed/NCBI
9	Hiss D: Optimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways. J Oncol. 2012:7379812012. View Article : Google Scholar : PubMed/NCBI
10	Jenkins DC, Charles IG, Thomsen LL, et al: Roles of nitric oxide in tumor growth. Proc Natl Acad Sci USA. 92:4392–4396. 1995. View Article : Google Scholar : PubMed/NCBI
11	Xu WM, Liu LZ, Loizidou M, Ahmed M and Charles IG: The role of nitric oxide in cancer. Cell Res. 12:311–320. 2002. View Article : Google Scholar
12	Chen GG, Lee TW, Xu H, Yip JH, Li M, Mok TS and Yim AP: Increased inducible nitric oxide synthase in lung carcinoma of smokers. Cancer. 112:372–381. 2008. View Article : Google Scholar : PubMed/NCBI
13	Wongvaranon P, Pongrakhananon V, Chunhacha P and Chanvorachote P: Acquired resistance to chemotherapy in lung cancer cells mediated by prolonged nitric oxide exposure. Anticancer Res. 33:5433–5444. 2013.PubMed/NCBI
14	Du Q, Zhang X, Liu Q, Zhang X, Bartels CE and Geller DA: Nitric oxide production upregulates Wnt/β-catenin signaling by inhibiting Dickkopf-1. Cancer Res. 73:6526–6537. 2013.PubMed/NCBI
15	Vane JR, Mitchell JA, Appleton I, et al: Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc Natl Acad Sci USA. 91:2046–2050. 1994. View Article : Google Scholar : PubMed/NCBI
16	Nathan C and Xie QW: Nitric oxide synthases: roles, tolls, and controls. Cell. 78:915–918. 1994. View Article : Google Scholar : PubMed/NCBI
17	Gonzalez D, Rojas A, Herrera MB and Conlan RS: iNOS activation regulates β-catenin association with its partners in endothelial cells. PLoS One. 7:e529642012.
18	Sumi T, Oki S, Kitajima K and Meno C: Epiblast ground state is controlled by canonical Wnt/β-catenin signaling in the post-implantation mouse embryo and epiblast stem cells. PLoS One. 8:e633782013.PubMed/NCBI
19	Tian XH, Hou WJ, Fang Y, et al: XAV939, a tankyrase 1 inhibitor, promotes cell apoptosis in neuroblastoma cell lines by inhibitingWnt/β-catenin signaling pathway. J Exp Clin Cancer Res. 32:1002013.
20	Gafni J, Munsch JA, Lam TH, et al: Xestospongins: potent membrane permeable blockers of the inositol 1,4,5-trisphosphate receptor. Neuron. 19:723–733. 1997. View Article : Google Scholar : PubMed/NCBI
21	Westfall TA, Brimeyer R, Twedt J, et al: Wnt-5/pipetail functions in vertebrate axis formation as a negative regulator of Wnt/beta-catenin activity. J Cell Biol. 162:889–898. 2003. View Article : Google Scholar : PubMed/NCBI
22	Cadigan KM and Nusse R: Wnt signaling: a common theme in animal development. Genes Dev. 11:3286–3305. 1997. View Article : Google Scholar : PubMed/NCBI
23	Logan CY and Nusse R: The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol. 20:781–810. 2004. View Article : Google Scholar : PubMed/NCBI
24	Moon RT, Brown JD and Torres M: WNTs modulate cell fate and behavior during vertebrate development. Trends Genet. 13:157–162. 1997. View Article : Google Scholar : PubMed/NCBI
25	Nakajima M, Fukuchi M, Miyazaki T, Masuda N, Kato H and Kuwano H: Reduced expression of Axin correlates with tumour progression of oesophageal squamous cell carcinoma. Br J Cancer. 88:1734–1739. 2003. View Article : Google Scholar : PubMed/NCBI
26	Bryja V, Andersson ER, Schambony A, et al: The extracellular domain of Lrp5/6 inhibits noncanonical Wnt signaling in vivo. Mol Biol Cell. 20:924–936. 2009. View Article : Google Scholar : PubMed/NCBI
27	Andersson ER, Bryjova L, Biris K, Yamaguchi TP, Arenas E and Bryja V: Genetic interaction between Lrp6 and Wnt5a during mouse development. Dev Dyn. 239:237–245. 2010.PubMed/NCBI
28	Gao C and Chen YG: Dishevelled: The hub of Wnt signaling. Cell Signal. 22:717–727. 2010. View Article : Google Scholar : PubMed/NCBI
29	Mikels AJ and Nusse R: Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context. PLoS Biol. 4:570–582. 2006. View Article : Google Scholar : PubMed/NCBI
30	Surana R, Sikka S, Cai W, Dharmarajan AM, Kumar AP, et al: Secreted frizzled related proteins: implications in cancers. Biochim Biophys Acta. 1845:53–65. 2014.PubMed/NCBI
31	Zhang J, Zhou B, Liu Y, et al: Wnt inhibitory factor-1 functions as a tumor suppressor through modulating Wnt/β-catenin signaling in neuroblastoma. Cancer Lett. 348:12–19. 2014.PubMed/NCBI
32	Kawano Y and Kypta R: Secreted antagonists of the Wnt signalling pathway. J Cell Sci. 116:2627–2634. 2003. View Article : Google Scholar : PubMed/NCBI
33	Bafico A, Liu G, Yaniv A, Gazit A and Aaronson SA: Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow. Nat Cell Biol. 3:683–686. 2001. View Article : Google Scholar : PubMed/NCBI
34	Du Q, Park KS, Guo Z, et al: Regulation of human nitric oxide synthase 2 expression by Wnt beta-catenin signaling. Cancer Res. 66:7024–7031. 2006. View Article : Google Scholar : PubMed/NCBI
35	Du Q, Zhang X, Cardinal J, et al: Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells. Cancer Res. 69:3764–3771. 2009. View Article : Google Scholar
36	Du Q and Geller DA: Cross-regulation between Wnt and NF-κB signaling pathways. For Immunopathol Dis Therap. 1:155–181. 2010.
37	Pakos EE and Ioannidis JP: The association of P-glycoprotein with response to chemotherapy and clinical outcome in patients with osteosarcoma. A meta-analysis. Cancer. 8:581–589. 2003. View Article : Google Scholar : PubMed/NCBI
38	Geng G, Wang L, Chen X, Cao R and Li P: The association between chemosensitivity and Pgp, GST-π and Topo II expression in gastric cancer. Diagn Pathol. 8:1982013.PubMed/NCBI
39	MacDonald BT and He X: Frizzled and LRP5/6 receptors for Wnt/β-catenin signaling. Cold Spring Harb Perspect Biol. 4:a0078802012.
40	Bourhis E, Tam C, Franke Y, et al: Reconstitution of a Frizzled8-Wnt3a-LRP6 signaling complex reveals multiple Wnt and Dkk1 binding sites on LRP6. J Biol Chem. 285:9172–9179. 2010. View Article : Google Scholar : PubMed/NCBI
41	Tamai K, Semenov M, Kato Y, et al: LDL-receptor-related proteins in Wnt signal transduction. Nature. 407:530–535. 2000. View Article : Google Scholar : PubMed/NCBI
42	Hsieh JC, Kodjabachian L, Rebbert ML, et al: A new secreted protein that binds to Wnt proteins and inhibits their activities. Nature. 398:431–436. 1999. View Article : Google Scholar : PubMed/NCBI
43	Surmann-Schmitt C, Widmann N, Dietz U, et al: Wif-1 is expressed at cartilage-mesenchyme interfaces and impedes Wnt3a-mediated inhibition of chondrogenesis. J Cell Sci. 122:3627–3637. 2009. View Article : Google Scholar : PubMed/NCBI